Products for Research Use Only
RegisterLogin

DOTA-CXCR4-L

CAT: 0013-GTR19061941-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19061941-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DOTA-CXCR4-L is a peptide-based research compound targeting the CXCR4 receptor. It is applied in oncology research, including studies on glioblastoma and triple-negative breast cancer, for in vitro and in vivo investigation of CXCR4-mediated signaling pathways.
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery
Molecular Weight
1223.34
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19267069-01DOTA-Tyr-Lys-DOTA
GTR19278512-01Janus-DOTA
GTR19248036-01Butyne-DOTA
GTR19248018-01DOTA-Thiol
GTR19193571Lysine-DOTA
GTR19189931Maleimide-DOTA
GTR19061998-01DOTA-LM3
GTR19061996-01DOTA-JR11
GTR19248032-01DOTA-amide
GTR19247895-01DOTA-4AMP

Alternative Products

CatalogName
HY-P5297DOTA-CXCR4-L
TRC-D535500-250MGDOTA
TYD-02727-01DOTA-Tyr-Lys-DOTA
BA5818-1DOTA-LM3
HY-P11254DOTA-FAPT
4029066.0250DOTA (OtBu) ₃
4029066.05DOTA(OtBu)₃
HY-W678394-01DOTA-Thiol
413907Gd-DOTA
HY-163039DOTA-biotin

Popular Products